SRTOY Stock, Sartorius Stedim Biotech S.A. ADR Information

Sartorius Stedim Biotech is a leading provider of tools for biopharmaceutical fermentation and fluid management. Parent Sartorius AG has a 74% stake in the company, with 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (38% of 2022 sales), the Americas (36%), and Asia-Pacific (26%). Sartorius Stedim Biotech employs over 10,000 people and has operations in more than 20 countries.